EPW
BIIB icon

Evolve Private Wealth’s Biogen BIIB Stock Holding History

Evolve Private Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Sell
2,032
-1,504
-43% -$288K 0.03% 568
2026
Q1 		$648K Buy
3,536
+353
+11% +$65K 0.03% 464
2025
Q4 		$560K Buy
+3,183
New +$520K 0.03% 491

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evolve Private Wealth's BIIB Position: Q2 2026 in Review

Evolve Private Wealth reduced its Biogen (BIIB) stake by 43% in Q2 2026, selling an estimated $288K and leaving 2,032 shares worth $439K. The position accounts for 0.03% of the portfolio, ranked #568.

Evolve Private Wealth first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. The position peaked at $648K in Q1 2026. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Evolve Private Wealth held 2,032 shares of Biogen worth $439K as of Q2 2026.
  • Evolve Private Wealth sold 1,504 Biogen shares in Q2 2026, an estimated $288K.
  • Biogen made up 0.03% of Evolve Private Wealth's portfolio in Q2 2026, its #568 holding.
  • Evolve Private Wealth first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • Evolve Private Wealth's Biogen position peaked at $648K in Q1 2026.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Evolve Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.